Global Biosimilars Drug Market Growth (Status and Outlook) 2026-2032
The global Biosimilars Drug market size is predicted to grow from US$ 5838 million in 2025 to US$ 28690 million in 2032; it is expected to grow at a CAGR of 26.0% from 2026 to 2032.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Biosimilars Drug Industry Forecast? looks at past sales and reviews total world Biosimilars Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Biosimilars Drug sales for 2026 through 2032. With Biosimilars Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars Drug industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biosimilars Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biosimilars Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original 'innovator' products and can manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the ?Biosimilars Drug Industry Forecast? looks at past sales and reviews total world Biosimilars Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Biosimilars Drug sales for 2026 through 2032. With Biosimilars Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biosimilars Drug industry.
This Insight Report provides a comprehensive analysis of the global Biosimilars Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biosimilars Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Biosimilars Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biosimilars Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biosimilars Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Monoclonal Antibodies
- Insulin
- Others
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Qilu Pharmaceutical
- Bio-Thera
- Zhejiang Hisun
- Shanghai Henlius
- Innovent Biologics
- Jiangsu Hengrui
- Gan&Lee
- Tonghua Dongbao
- United Laboratory
- 3SBIO
- Luye Pharma
- Celltrion
- Pfizer
- Novartis
- Dr Reddy?s
- Celgen Biopharma
- Eli Lilly
- Sanofi
- Geropharm
- Biocon
- Wockhardt
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars Drug Market Size (2021-2032)
2.1.2 Biosimilars Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biosimilars Drug by Country/Region (2021, 2025 & 2032)
2.2 Biosimilars Drug Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Insulin
2.2.3 Others
2.2.4 Biosimilars Drug Market Size by Type
2.2.4.1 Biosimilars Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Biosimilars Drug Market Size Market Share by Type (2021-2026)
2.3 Biosimilars Drug Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Other
2.3.4 Biosimilars Drug Market Size by Application
2.3.4.1 Biosimilars Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biosimilars Drug Market Size Market Share by Application (2021-2026)
3 BIOSIMILARS DRUG MARKET SIZE BY PLAYER
3.1 Biosimilars Drug Market Size Market Share by Player
3.1.1 Global Biosimilars Drug Revenue by Player (2021-2026)
3.1.2 Global Biosimilars Drug Revenue Market Share by Player (2021-2026)
3.2 Global Biosimilars Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILARS DRUG BY REGION
4.1 Biosimilars Drug Market Size by Region (2021-2026)
4.2 Global Biosimilars Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biosimilars Drug Market Size Growth (2021-2026)
4.4 APAC Biosimilars Drug Market Size Growth (2021-2026)
4.5 Europe Biosimilars Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Biosimilars Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biosimilars Drug Market Size by Country (2021-2026)
5.2 Americas Biosimilars Drug Market Size by Type (2021-2026)
5.3 Americas Biosimilars Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars Drug Market Size by Region (2021-2026)
6.2 APAC Biosimilars Drug Market Size by Type (2021-2026)
6.3 APAC Biosimilars Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilars Drug Market Size by Country (2021-2026)
7.2 Europe Biosimilars Drug Market Size by Type (2021-2026)
7.3 Europe Biosimilars Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars Drug by Region (2021-2026)
8.2 Middle East & Africa Biosimilars Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Biosimilars Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILARS DRUG MARKET FORECAST
10.1 Global Biosimilars Drug Forecast by Region (2027-2032)
10.1.1 Global Biosimilars Drug Forecast by Region (2027-2032)
10.1.2 Americas Biosimilars Drug Forecast
10.1.3 APAC Biosimilars Drug Forecast
10.1.4 Europe Biosimilars Drug Forecast
10.1.5 Middle East & Africa Biosimilars Drug Forecast
10.2 Americas Biosimilars Drug Forecast by Country (2027-2032)
10.2.1 United States Market Biosimilars Drug Forecast
10.2.2 Canada Market Biosimilars Drug Forecast
10.2.3 Mexico Market Biosimilars Drug Forecast
10.2.4 Brazil Market Biosimilars Drug Forecast
10.3 APAC Biosimilars Drug Forecast by Region (2027-2032)
10.3.1 China Biosimilars Drug Market Forecast
10.3.2 Japan Market Biosimilars Drug Forecast
10.3.3 Korea Market Biosimilars Drug Forecast
10.3.4 Southeast Asia Market Biosimilars Drug Forecast
10.3.5 India Market Biosimilars Drug Forecast
10.3.6 Australia Market Biosimilars Drug Forecast
10.4 Europe Biosimilars Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Biosimilars Drug Forecast
10.4.2 France Market Biosimilars Drug Forecast
10.4.3 UK Market Biosimilars Drug Forecast
10.4.4 Italy Market Biosimilars Drug Forecast
10.4.5 Russia Market Biosimilars Drug Forecast
10.5 Middle East & Africa Biosimilars Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Biosimilars Drug Forecast
10.5.2 South Africa Market Biosimilars Drug Forecast
10.5.3 Israel Market Biosimilars Drug Forecast
10.5.4 Turkey Market Biosimilars Drug Forecast
10.6 Global Biosimilars Drug Forecast by Type (2027-2032)
10.7 Global Biosimilars Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biosimilars Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Biosimilars Drug Product Offered
11.1.3 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Qilu Pharmaceutical Main Business Overview
11.1.5 Qilu Pharmaceutical Latest Developments
11.2 Bio-Thera
11.2.1 Bio-Thera Company Information
11.2.2 Bio-Thera Biosimilars Drug Product Offered
11.2.3 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Thera Main Business Overview
11.2.5 Bio-Thera Latest Developments
11.3 Zhejiang Hisun
11.3.1 Zhejiang Hisun Company Information
11.3.2 Zhejiang Hisun Biosimilars Drug Product Offered
11.3.3 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zhejiang Hisun Main Business Overview
11.3.5 Zhejiang Hisun Latest Developments
11.4 Shanghai Henlius
11.4.1 Shanghai Henlius Company Information
11.4.2 Shanghai Henlius Biosimilars Drug Product Offered
11.4.3 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Shanghai Henlius Main Business Overview
11.4.5 Shanghai Henlius Latest Developments
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Information
11.5.2 Innovent Biologics Biosimilars Drug Product Offered
11.5.3 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Innovent Biologics Main Business Overview
11.5.5 Innovent Biologics Latest Developments
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Information
11.6.2 Jiangsu Hengrui Biosimilars Drug Product Offered
11.6.3 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jiangsu Hengrui Main Business Overview
11.6.5 Jiangsu Hengrui Latest Developments
11.7 Gan&Lee
11.7.1 Gan&Lee Company Information
11.7.2 Gan&Lee Biosimilars Drug Product Offered
11.7.3 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Gan&Lee Main Business Overview
11.7.5 Gan&Lee Latest Developments
11.8 Tonghua Dongbao
11.8.1 Tonghua Dongbao Company Information
11.8.2 Tonghua Dongbao Biosimilars Drug Product Offered
11.8.3 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Tonghua Dongbao Main Business Overview
11.8.5 Tonghua Dongbao Latest Developments
11.9 United Laboratory
11.9.1 United Laboratory Company Information
11.9.2 United Laboratory Biosimilars Drug Product Offered
11.9.3 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 United Laboratory Main Business Overview
11.9.5 United Laboratory Latest Developments
11.10 3SBIO
11.10.1 3SBIO Company Information
11.10.2 3SBIO Biosimilars Drug Product Offered
11.10.3 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 3SBIO Main Business Overview
11.10.5 3SBIO Latest Developments
11.11 Luye Pharma
11.11.1 Luye Pharma Company Information
11.11.2 Luye Pharma Biosimilars Drug Product Offered
11.11.3 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Luye Pharma Main Business Overview
11.11.5 Luye Pharma Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biosimilars Drug Product Offered
11.12.3 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Biosimilars Drug Product Offered
11.13.3 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Pfizer Main Business Overview
11.13.5 Pfizer Latest Developments
11.14 Novartis
11.14.1 Novartis Company Information
11.14.2 Novartis Biosimilars Drug Product Offered
11.14.3 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novartis Main Business Overview
11.14.5 Novartis Latest Developments
11.15 Dr Reddy?s
11.15.1 Dr Reddy?s Company Information
11.15.2 Dr Reddy?s Biosimilars Drug Product Offered
11.15.3 Dr Reddy?s Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Dr Reddy?s Main Business Overview
11.15.5 Dr Reddy?s Latest Developments
11.16 Celgen Biopharma
11.16.1 Celgen Biopharma Company Information
11.16.2 Celgen Biopharma Biosimilars Drug Product Offered
11.16.3 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Celgen Biopharma Main Business Overview
11.16.5 Celgen Biopharma Latest Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Information
11.17.2 Eli Lilly Biosimilars Drug Product Offered
11.17.3 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Eli Lilly Main Business Overview
11.17.5 Eli Lilly Latest Developments
11.18 Sanofi
11.18.1 Sanofi Company Information
11.18.2 Sanofi Biosimilars Drug Product Offered
11.18.3 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Sanofi Main Business Overview
11.18.5 Sanofi Latest Developments
11.19 Geropharm
11.19.1 Geropharm Company Information
11.19.2 Geropharm Biosimilars Drug Product Offered
11.19.3 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Geropharm Main Business Overview
11.19.5 Geropharm Latest Developments
11.20 Biocon
11.20.1 Biocon Company Information
11.20.2 Biocon Biosimilars Drug Product Offered
11.20.3 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Biocon Main Business Overview
11.20.5 Biocon Latest Developments
11.21 Wockhardt
11.21.1 Wockhardt Company Information
11.21.2 Wockhardt Biosimilars Drug Product Offered
11.21.3 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Wockhardt Main Business Overview
11.21.5 Wockhardt Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biosimilars Drug Market Size (2021-2032)
2.1.2 Biosimilars Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Biosimilars Drug by Country/Region (2021, 2025 & 2032)
2.2 Biosimilars Drug Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Insulin
2.2.3 Others
2.2.4 Biosimilars Drug Market Size by Type
2.2.4.1 Biosimilars Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Biosimilars Drug Market Size Market Share by Type (2021-2026)
2.3 Biosimilars Drug Segment by Application
2.3.1 Hospital
2.3.2 Retail Pharmacy
2.3.3 Other
2.3.4 Biosimilars Drug Market Size by Application
2.3.4.1 Biosimilars Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Biosimilars Drug Market Size Market Share by Application (2021-2026)
3 BIOSIMILARS DRUG MARKET SIZE BY PLAYER
3.1 Biosimilars Drug Market Size Market Share by Player
3.1.1 Global Biosimilars Drug Revenue by Player (2021-2026)
3.1.2 Global Biosimilars Drug Revenue Market Share by Player (2021-2026)
3.2 Global Biosimilars Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOSIMILARS DRUG BY REGION
4.1 Biosimilars Drug Market Size by Region (2021-2026)
4.2 Global Biosimilars Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Biosimilars Drug Market Size Growth (2021-2026)
4.4 APAC Biosimilars Drug Market Size Growth (2021-2026)
4.5 Europe Biosimilars Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Biosimilars Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Biosimilars Drug Market Size by Country (2021-2026)
5.2 Americas Biosimilars Drug Market Size by Type (2021-2026)
5.3 Americas Biosimilars Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilars Drug Market Size by Region (2021-2026)
6.2 APAC Biosimilars Drug Market Size by Type (2021-2026)
6.3 APAC Biosimilars Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biosimilars Drug Market Size by Country (2021-2026)
7.2 Europe Biosimilars Drug Market Size by Type (2021-2026)
7.3 Europe Biosimilars Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biosimilars Drug by Region (2021-2026)
8.2 Middle East & Africa Biosimilars Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Biosimilars Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOSIMILARS DRUG MARKET FORECAST
10.1 Global Biosimilars Drug Forecast by Region (2027-2032)
10.1.1 Global Biosimilars Drug Forecast by Region (2027-2032)
10.1.2 Americas Biosimilars Drug Forecast
10.1.3 APAC Biosimilars Drug Forecast
10.1.4 Europe Biosimilars Drug Forecast
10.1.5 Middle East & Africa Biosimilars Drug Forecast
10.2 Americas Biosimilars Drug Forecast by Country (2027-2032)
10.2.1 United States Market Biosimilars Drug Forecast
10.2.2 Canada Market Biosimilars Drug Forecast
10.2.3 Mexico Market Biosimilars Drug Forecast
10.2.4 Brazil Market Biosimilars Drug Forecast
10.3 APAC Biosimilars Drug Forecast by Region (2027-2032)
10.3.1 China Biosimilars Drug Market Forecast
10.3.2 Japan Market Biosimilars Drug Forecast
10.3.3 Korea Market Biosimilars Drug Forecast
10.3.4 Southeast Asia Market Biosimilars Drug Forecast
10.3.5 India Market Biosimilars Drug Forecast
10.3.6 Australia Market Biosimilars Drug Forecast
10.4 Europe Biosimilars Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Biosimilars Drug Forecast
10.4.2 France Market Biosimilars Drug Forecast
10.4.3 UK Market Biosimilars Drug Forecast
10.4.4 Italy Market Biosimilars Drug Forecast
10.4.5 Russia Market Biosimilars Drug Forecast
10.5 Middle East & Africa Biosimilars Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Biosimilars Drug Forecast
10.5.2 South Africa Market Biosimilars Drug Forecast
10.5.3 Israel Market Biosimilars Drug Forecast
10.5.4 Turkey Market Biosimilars Drug Forecast
10.6 Global Biosimilars Drug Forecast by Type (2027-2032)
10.7 Global Biosimilars Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Biosimilars Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Biosimilars Drug Product Offered
11.1.3 Qilu Pharmaceutical Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Qilu Pharmaceutical Main Business Overview
11.1.5 Qilu Pharmaceutical Latest Developments
11.2 Bio-Thera
11.2.1 Bio-Thera Company Information
11.2.2 Bio-Thera Biosimilars Drug Product Offered
11.2.3 Bio-Thera Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bio-Thera Main Business Overview
11.2.5 Bio-Thera Latest Developments
11.3 Zhejiang Hisun
11.3.1 Zhejiang Hisun Company Information
11.3.2 Zhejiang Hisun Biosimilars Drug Product Offered
11.3.3 Zhejiang Hisun Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Zhejiang Hisun Main Business Overview
11.3.5 Zhejiang Hisun Latest Developments
11.4 Shanghai Henlius
11.4.1 Shanghai Henlius Company Information
11.4.2 Shanghai Henlius Biosimilars Drug Product Offered
11.4.3 Shanghai Henlius Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Shanghai Henlius Main Business Overview
11.4.5 Shanghai Henlius Latest Developments
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Information
11.5.2 Innovent Biologics Biosimilars Drug Product Offered
11.5.3 Innovent Biologics Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Innovent Biologics Main Business Overview
11.5.5 Innovent Biologics Latest Developments
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Information
11.6.2 Jiangsu Hengrui Biosimilars Drug Product Offered
11.6.3 Jiangsu Hengrui Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jiangsu Hengrui Main Business Overview
11.6.5 Jiangsu Hengrui Latest Developments
11.7 Gan&Lee
11.7.1 Gan&Lee Company Information
11.7.2 Gan&Lee Biosimilars Drug Product Offered
11.7.3 Gan&Lee Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Gan&Lee Main Business Overview
11.7.5 Gan&Lee Latest Developments
11.8 Tonghua Dongbao
11.8.1 Tonghua Dongbao Company Information
11.8.2 Tonghua Dongbao Biosimilars Drug Product Offered
11.8.3 Tonghua Dongbao Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Tonghua Dongbao Main Business Overview
11.8.5 Tonghua Dongbao Latest Developments
11.9 United Laboratory
11.9.1 United Laboratory Company Information
11.9.2 United Laboratory Biosimilars Drug Product Offered
11.9.3 United Laboratory Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 United Laboratory Main Business Overview
11.9.5 United Laboratory Latest Developments
11.10 3SBIO
11.10.1 3SBIO Company Information
11.10.2 3SBIO Biosimilars Drug Product Offered
11.10.3 3SBIO Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 3SBIO Main Business Overview
11.10.5 3SBIO Latest Developments
11.11 Luye Pharma
11.11.1 Luye Pharma Company Information
11.11.2 Luye Pharma Biosimilars Drug Product Offered
11.11.3 Luye Pharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Luye Pharma Main Business Overview
11.11.5 Luye Pharma Latest Developments
11.12 Celltrion
11.12.1 Celltrion Company Information
11.12.2 Celltrion Biosimilars Drug Product Offered
11.12.3 Celltrion Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Celltrion Main Business Overview
11.12.5 Celltrion Latest Developments
11.13 Pfizer
11.13.1 Pfizer Company Information
11.13.2 Pfizer Biosimilars Drug Product Offered
11.13.3 Pfizer Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Pfizer Main Business Overview
11.13.5 Pfizer Latest Developments
11.14 Novartis
11.14.1 Novartis Company Information
11.14.2 Novartis Biosimilars Drug Product Offered
11.14.3 Novartis Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Novartis Main Business Overview
11.14.5 Novartis Latest Developments
11.15 Dr Reddy?s
11.15.1 Dr Reddy?s Company Information
11.15.2 Dr Reddy?s Biosimilars Drug Product Offered
11.15.3 Dr Reddy?s Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Dr Reddy?s Main Business Overview
11.15.5 Dr Reddy?s Latest Developments
11.16 Celgen Biopharma
11.16.1 Celgen Biopharma Company Information
11.16.2 Celgen Biopharma Biosimilars Drug Product Offered
11.16.3 Celgen Biopharma Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Celgen Biopharma Main Business Overview
11.16.5 Celgen Biopharma Latest Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Information
11.17.2 Eli Lilly Biosimilars Drug Product Offered
11.17.3 Eli Lilly Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Eli Lilly Main Business Overview
11.17.5 Eli Lilly Latest Developments
11.18 Sanofi
11.18.1 Sanofi Company Information
11.18.2 Sanofi Biosimilars Drug Product Offered
11.18.3 Sanofi Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Sanofi Main Business Overview
11.18.5 Sanofi Latest Developments
11.19 Geropharm
11.19.1 Geropharm Company Information
11.19.2 Geropharm Biosimilars Drug Product Offered
11.19.3 Geropharm Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Geropharm Main Business Overview
11.19.5 Geropharm Latest Developments
11.20 Biocon
11.20.1 Biocon Company Information
11.20.2 Biocon Biosimilars Drug Product Offered
11.20.3 Biocon Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Biocon Main Business Overview
11.20.5 Biocon Latest Developments
11.21 Wockhardt
11.21.1 Wockhardt Company Information
11.21.2 Wockhardt Biosimilars Drug Product Offered
11.21.3 Wockhardt Biosimilars Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Wockhardt Main Business Overview
11.21.5 Wockhardt Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biosimilars Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biosimilars Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Insulin
Table 5. Major Players of Others
Table 6. Biosimilars Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Biosimilars Drug Market Size Market Share by Type (2021-2026)
Table 9. Biosimilars Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Biosimilars Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Biosimilars Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Biosimilars Drug Revenue Market Share by Player (2021-2026)
Table 14. Biosimilars Drug Key Players Head office and Products Offered
Table 15. Biosimilars Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Biosimilars Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Biosimilars Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Biosimilars Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Biosimilars Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Biosimilars Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Biosimilars Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Biosimilars Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Biosimilars Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Biosimilars Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Biosimilars Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Biosimilars Drug
Table 40. Key Market Challenges & Risks of Biosimilars Drug
Table 41. Key Industry Trends of Biosimilars Drug
Table 42. Global Biosimilars Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Biosimilars Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Biosimilars Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Biosimilars Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Qilu Pharmaceutical Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 47. Qilu Pharmaceutical Biosimilars Drug Product Offered
Table 48. Qilu Pharmaceutical Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Qilu Pharmaceutical Main Business
Table 50. Qilu Pharmaceutical Latest Developments
Table 51. Bio-Thera Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 52. Bio-Thera Biosimilars Drug Product Offered
Table 53. Bio-Thera Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bio-Thera Main Business
Table 55. Bio-Thera Latest Developments
Table 56. Zhejiang Hisun Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 57. Zhejiang Hisun Biosimilars Drug Product Offered
Table 58. Zhejiang Hisun Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Zhejiang Hisun Main Business
Table 60. Zhejiang Hisun Latest Developments
Table 61. Shanghai Henlius Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 62. Shanghai Henlius Biosimilars Drug Product Offered
Table 63. Shanghai Henlius Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Shanghai Henlius Main Business
Table 65. Shanghai Henlius Latest Developments
Table 66. Innovent Biologics Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 67. Innovent Biologics Biosimilars Drug Product Offered
Table 68. Innovent Biologics Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Innovent Biologics Main Business
Table 70. Innovent Biologics Latest Developments
Table 71. Jiangsu Hengrui Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 72. Jiangsu Hengrui Biosimilars Drug Product Offered
Table 73. Jiangsu Hengrui Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Jiangsu Hengrui Main Business
Table 75. Jiangsu Hengrui Latest Developments
Table 76. Gan&Lee Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 77. Gan&Lee Biosimilars Drug Product Offered
Table 78. Gan&Lee Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Gan&Lee Main Business
Table 80. Gan&Lee Latest Developments
Table 81. Tonghua Dongbao Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 82. Tonghua Dongbao Biosimilars Drug Product Offered
Table 83. Tonghua Dongbao Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Tonghua Dongbao Main Business
Table 85. Tonghua Dongbao Latest Developments
Table 86. United Laboratory Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 87. United Laboratory Biosimilars Drug Product Offered
Table 88. United Laboratory Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. United Laboratory Main Business
Table 90. United Laboratory Latest Developments
Table 91. 3SBIO Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 92. 3SBIO Biosimilars Drug Product Offered
Table 93. 3SBIO Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. 3SBIO Main Business
Table 95. 3SBIO Latest Developments
Table 96. Luye Pharma Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 97. Luye Pharma Biosimilars Drug Product Offered
Table 98. Luye Pharma Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Luye Pharma Main Business
Table 100. Luye Pharma Latest Developments
Table 101. Celltrion Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 102. Celltrion Biosimilars Drug Product Offered
Table 103. Celltrion Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Celltrion Main Business
Table 105. Celltrion Latest Developments
Table 106. Pfizer Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 107. Pfizer Biosimilars Drug Product Offered
Table 108. Pfizer Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. Novartis Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 112. Novartis Biosimilars Drug Product Offered
Table 113. Novartis Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Novartis Main Business
Table 115. Novartis Latest Developments
Table 116. Dr Reddy?s Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 117. Dr Reddy?s Biosimilars Drug Product Offered
Table 118. Dr Reddy?s Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Dr Reddy?s Main Business
Table 120. Dr Reddy?s Latest Developments
Table 121. Celgen Biopharma Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 122. Celgen Biopharma Biosimilars Drug Product Offered
Table 123. Celgen Biopharma Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Celgen Biopharma Main Business
Table 125. Celgen Biopharma Latest Developments
Table 126. Eli Lilly Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 127. Eli Lilly Biosimilars Drug Product Offered
Table 128. Eli Lilly Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. Sanofi Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 132. Sanofi Biosimilars Drug Product Offered
Table 133. Sanofi Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Sanofi Main Business
Table 135. Sanofi Latest Developments
Table 136. Geropharm Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 137. Geropharm Biosimilars Drug Product Offered
Table 138. Geropharm Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Geropharm Main Business
Table 140. Geropharm Latest Developments
Table 141. Biocon Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 142. Biocon Biosimilars Drug Product Offered
Table 143. Biocon Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Biocon Main Business
Table 145. Biocon Latest Developments
Table 146. Wockhardt Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 147. Wockhardt Biosimilars Drug Product Offered
Table 148. Wockhardt Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Wockhardt Main Business
Table 150. Wockhardt Latest Developments
Table 1. Biosimilars Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Biosimilars Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monoclonal Antibodies
Table 4. Major Players of Insulin
Table 5. Major Players of Others
Table 6. Biosimilars Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Biosimilars Drug Market Size Market Share by Type (2021-2026)
Table 9. Biosimilars Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Biosimilars Drug Market Size Market Share by Application (2021-2026)
Table 12. Global Biosimilars Drug Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Biosimilars Drug Revenue Market Share by Player (2021-2026)
Table 14. Biosimilars Drug Key Players Head office and Products Offered
Table 15. Biosimilars Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Biosimilars Drug Market Size Market Share by Region (2021-2026)
Table 20. Global Biosimilars Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Biosimilars Drug Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Biosimilars Drug Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Biosimilars Drug Market Size Market Share by Country (2021-2026)
Table 24. Americas Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Biosimilars Drug Market Size Market Share by Type (2021-2026)
Table 26. Americas Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Biosimilars Drug Market Size Market Share by Application (2021-2026)
Table 28. APAC Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Biosimilars Drug Market Size Market Share by Region (2021-2026)
Table 30. APAC Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Biosimilars Drug Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Biosimilars Drug Market Size Market Share by Country (2021-2026)
Table 34. Europe Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Biosimilars Drug Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Biosimilars Drug Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Biosimilars Drug Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Biosimilars Drug
Table 40. Key Market Challenges & Risks of Biosimilars Drug
Table 41. Key Industry Trends of Biosimilars Drug
Table 42. Global Biosimilars Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Biosimilars Drug Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Biosimilars Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Biosimilars Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Qilu Pharmaceutical Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 47. Qilu Pharmaceutical Biosimilars Drug Product Offered
Table 48. Qilu Pharmaceutical Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Qilu Pharmaceutical Main Business
Table 50. Qilu Pharmaceutical Latest Developments
Table 51. Bio-Thera Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 52. Bio-Thera Biosimilars Drug Product Offered
Table 53. Bio-Thera Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Bio-Thera Main Business
Table 55. Bio-Thera Latest Developments
Table 56. Zhejiang Hisun Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 57. Zhejiang Hisun Biosimilars Drug Product Offered
Table 58. Zhejiang Hisun Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Zhejiang Hisun Main Business
Table 60. Zhejiang Hisun Latest Developments
Table 61. Shanghai Henlius Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 62. Shanghai Henlius Biosimilars Drug Product Offered
Table 63. Shanghai Henlius Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Shanghai Henlius Main Business
Table 65. Shanghai Henlius Latest Developments
Table 66. Innovent Biologics Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 67. Innovent Biologics Biosimilars Drug Product Offered
Table 68. Innovent Biologics Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Innovent Biologics Main Business
Table 70. Innovent Biologics Latest Developments
Table 71. Jiangsu Hengrui Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 72. Jiangsu Hengrui Biosimilars Drug Product Offered
Table 73. Jiangsu Hengrui Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Jiangsu Hengrui Main Business
Table 75. Jiangsu Hengrui Latest Developments
Table 76. Gan&Lee Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 77. Gan&Lee Biosimilars Drug Product Offered
Table 78. Gan&Lee Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Gan&Lee Main Business
Table 80. Gan&Lee Latest Developments
Table 81. Tonghua Dongbao Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 82. Tonghua Dongbao Biosimilars Drug Product Offered
Table 83. Tonghua Dongbao Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Tonghua Dongbao Main Business
Table 85. Tonghua Dongbao Latest Developments
Table 86. United Laboratory Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 87. United Laboratory Biosimilars Drug Product Offered
Table 88. United Laboratory Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. United Laboratory Main Business
Table 90. United Laboratory Latest Developments
Table 91. 3SBIO Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 92. 3SBIO Biosimilars Drug Product Offered
Table 93. 3SBIO Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. 3SBIO Main Business
Table 95. 3SBIO Latest Developments
Table 96. Luye Pharma Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 97. Luye Pharma Biosimilars Drug Product Offered
Table 98. Luye Pharma Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Luye Pharma Main Business
Table 100. Luye Pharma Latest Developments
Table 101. Celltrion Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 102. Celltrion Biosimilars Drug Product Offered
Table 103. Celltrion Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Celltrion Main Business
Table 105. Celltrion Latest Developments
Table 106. Pfizer Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 107. Pfizer Biosimilars Drug Product Offered
Table 108. Pfizer Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. Novartis Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 112. Novartis Biosimilars Drug Product Offered
Table 113. Novartis Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Novartis Main Business
Table 115. Novartis Latest Developments
Table 116. Dr Reddy?s Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 117. Dr Reddy?s Biosimilars Drug Product Offered
Table 118. Dr Reddy?s Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. Dr Reddy?s Main Business
Table 120. Dr Reddy?s Latest Developments
Table 121. Celgen Biopharma Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 122. Celgen Biopharma Biosimilars Drug Product Offered
Table 123. Celgen Biopharma Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Celgen Biopharma Main Business
Table 125. Celgen Biopharma Latest Developments
Table 126. Eli Lilly Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 127. Eli Lilly Biosimilars Drug Product Offered
Table 128. Eli Lilly Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Latest Developments
Table 131. Sanofi Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 132. Sanofi Biosimilars Drug Product Offered
Table 133. Sanofi Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Sanofi Main Business
Table 135. Sanofi Latest Developments
Table 136. Geropharm Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 137. Geropharm Biosimilars Drug Product Offered
Table 138. Geropharm Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 139. Geropharm Main Business
Table 140. Geropharm Latest Developments
Table 141. Biocon Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 142. Biocon Biosimilars Drug Product Offered
Table 143. Biocon Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 144. Biocon Main Business
Table 145. Biocon Latest Developments
Table 146. Wockhardt Details, Company Type, Biosimilars Drug Area Served and Its Competitors
Table 147. Wockhardt Biosimilars Drug Product Offered
Table 148. Wockhardt Biosimilars Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 149. Wockhardt Main Business
Table 150. Wockhardt Latest Developments
LIST OF FIGURES
Figure 1. Biosimilars Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biosimilars Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biosimilars Drug Sales Market Share by Country/Region (2025)
Figure 8. Biosimilars Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biosimilars Drug Market Size Market Share by Type in 2025
Figure 10. Biosimilars Drug in Hospital
Figure 11. Global Biosimilars Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Biosimilars Drug in Retail Pharmacy
Figure 13. Global Biosimilars Drug Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 14. Biosimilars Drug in Other
Figure 15. Global Biosimilars Drug Market: Other (2021-2026) & ($ millions)
Figure 16. Global Biosimilars Drug Market Size Market Share by Application in 2025
Figure 17. Global Biosimilars Drug Revenue Market Share by Player in 2025
Figure 18. Global Biosimilars Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Biosimilars Drug Value Market Share by Country in 2025
Figure 24. United States Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biosimilars Drug Market Size Market Share by Region in 2025
Figure 29. APAC Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biosimilars Drug Market Size Market Share by Country in 2025
Figure 38. Europe Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biosimilars Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 61. China Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 65. India Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 68. France Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Biosimilars Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biosimilars Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 1. Biosimilars Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilars Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Biosimilars Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Biosimilars Drug Sales Market Share by Country/Region (2025)
Figure 8. Biosimilars Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Biosimilars Drug Market Size Market Share by Type in 2025
Figure 10. Biosimilars Drug in Hospital
Figure 11. Global Biosimilars Drug Market: Hospital (2021-2026) & ($ millions)
Figure 12. Biosimilars Drug in Retail Pharmacy
Figure 13. Global Biosimilars Drug Market: Retail Pharmacy (2021-2026) & ($ millions)
Figure 14. Biosimilars Drug in Other
Figure 15. Global Biosimilars Drug Market: Other (2021-2026) & ($ millions)
Figure 16. Global Biosimilars Drug Market Size Market Share by Application in 2025
Figure 17. Global Biosimilars Drug Revenue Market Share by Player in 2025
Figure 18. Global Biosimilars Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Biosimilars Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Biosimilars Drug Value Market Share by Country in 2025
Figure 24. United States Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Biosimilars Drug Market Size Market Share by Region in 2025
Figure 29. APAC Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Biosimilars Drug Market Size Market Share by Country in 2025
Figure 38. Europe Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Biosimilars Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Biosimilars Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Biosimilars Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Biosimilars Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 61. China Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 65. India Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 68. France Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Biosimilars Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Biosimilars Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Biosimilars Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Biosimilars Drug Market Size 2027-2032 ($ millions)
